Global Ibuprofen Sales Market Report 2021
SKU ID : QYR-17364528 | Publishing Date : 09-Feb-2021 | No. of pages : 137
China is the largest supplier of Ibuprofen, with a production market share nearly 48% in 2016. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30.7% in 2016. Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Ibuprofen Market
The global Ibuprofen market was valued at US$ 331.7 in 2020 and will reach US$ 462.5 million by the end of 2027, growing at a CAGR of 5.7% during 2022-2027.
Global Ibuprofen Scope and Market Size
The global Ibuprofen market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
USP
EP
Segment by Application
Tablet
Capsule
Suspension
Others
The Ibuprofen market is analysed and market size information is provided by regions (countries). Segment by Application, the Ibuprofen market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Xinhua-Perrigo Pharmaceutical
Hisoar
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region